Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial

Guardat en:

Dades bibliogràfiques
Publicat a:	Clinical and Translational Science vol. 18, no. 5 (May 1, 2025)
Autor principal:	Capozza, Thomas
Altres autors:	Burkey, Jennifer, Van De Wetering, Jeroen, Kerb, Reinhold, Callahan, Jennifer, Kryzhanovskaya, Ludmila, Erickson, Mary
Publicat:	John Wiley & Sons, Inc.
Matèries:	European Union Netherlands Acids Bile Pharmacodynamics Pharmacokinetics Agonists Pruritus Dosage Lipid metabolism Urine Metabolism Liver diseases Ethics Body mass index Metabolites Drug dosages
Accés en línia:	Citation/Abstract Full Text Full Text - PDF
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!